Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Generex, PharmaBrand to establish joint venture for Oralin in Latin America

March 31, 2004

The Prous Science Broadcasting Division presents coverage of the AAOS meeting

March 31, 2004

Benefits of leptin replacement therapy in morbidly obese patients

March 30, 2004

Novel SARM for age-related muscle decline presented at ACS

March 30, 2004

Promising effects of rhC1INH in hereditary angioedema

March 30, 2004

Final results of the ACTION I study for pimagedine in diabetic nephropathy

March 29, 2004

Follistim-AQ receives FDA approval

March 29, 2004

Novel progesterone receptor modulators and their use in contraception and gynecological disorders

March 29, 2004

Novel DPP-IV inhibitors under study at Takeda

March 29, 2004

European Commission approves extended labeling for Xenical

March 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...